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ABSTRACT 
We have previously proposed the hypothesis that asymmetric membranes behave 
like bilayer couples: the two layers of the bilayer membrane  can respond differ- 
ently to a particular perturbation.  Such a perturbation,  for example, can result in 
the expansion of one layer relative to the other, thereby producing a curvature of 
that  membrane.  In  experiments  with  erythrocytes  and  lymphocytes,  we  now 
demonstrate  that  different  membrane  perturbations  which have opposite  effects 
on membrane curvature can compensate and neutralize one another, as expected 
from the bilayer couple hypothesis. This provides a rational basis, for example, for 
understanding the effects of amphipathic drugs on a variety of cellular phenomena 
which involve shape changes of membranes. 
In two recent papers (14,  15) we have proposed 
and experimentally tested the hypothesis that bio- 
logical  membranes  behave  like  bilayer  couples; 
that is, the two halves of the bilayer membrane, if 
they differ in their protein and lipid constituents, 
can  respond  differently  to  membrane  perturba- 
tions.  For  example,  the  two  half-layers  of  the 
membrane may expand or contract differently in 
the  plane  of  the  membrane;  if  the  membrane 
forms a  closed  surface,  a  change  in  the  relative 
surface  areas  of  the  two  halves  would  lead  to 
changes in  the curvature of the  membrane.  This 
hypothesis was then applied to the interaction of 
amphipathic  drugs  with  intact  human  erythro- 
cytes. A  wide range of drugs, most of them nega- 
tively charged under physiological conditions, are 
known to cause erythrocytes to crenate; another 
broad spectrum  of drugs,  all  positively charged, 
cause the erythrocyte to assume an invaginated or 
cup shape  (3).  It was proposed  (14)  that in  the 
concentration  ranges  in  which they induce these 
shape changes, all of these drugs bind to the mem- 
brane by intercalating their hydrophobic portions 
into the lipid  bilayer with their ionic heads in the 
membrane  surfaces;  and  that  drugs  which  are 
crenators bind preferentially into and expand the 
outer half-layer of the membrane, while the cup- 
formers bind  preferentially  into  and  expand  the 
inner  half-layer,  thus  producing  the  respective 
shape  changes  observed.  The  different  equilib- 
rium  binding  of anionic  crenators  and  cationic 
cup-formers to the lipid  in the two half-layers of 
the erythrocyte membrane was attributed to elec- 
trostatic  interaction  with  the  negatively  charged 
lipid phosphatidylserine which is largly confined to 
the inner half-layer (1,5, 23). A mechanical treat- 
ment of the bending of bilayers has led Evans (4) 
to  suggest  independently  that  the  drug-induced 
crenation of intact erythrocytes is due to an expan- 
sion  of outer  vs.  inner  half-layers  of the  mem- 
brane. 
In principle, any of a wide variety of membrane 
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proteins  of  the  membrane,  might  result  in  a 
change in the relative surface areas of the two half- 
layers of the membrane, with a resultant change in 
membrane shape. In other words, by quite differ- 
ent molecular mechanisms, similar area and shape 
changes  might be  induced in  membranes. As  a 
corollary, if any two independent membrane per- 
turbations have opposite effects on the ratios of 
outer and inner surface areas, they might compen- 
sate  for  one  another  and  neutralize  the  shape 
changes each alone induces. This proposal is sub- 
jected to the following experimental tests in this 
paper. 
(a) It is known (3) that when a compound that is 
a crenator and one that is a cup-former are simul- 
taneously added to  intact erythrocytes, the  cells 
retain  their  normal biconcave  disk  shape.  This 
would constitute a compensatory shape change of 
the type described above, if it could be established 
that both compounds are simultaneously  bound in 
the cell membrane. We therefore have carried out 
experiments  with  intact  erythrocytes  to  which 
oleate  (a  crenator)  and  chlorpromazine (a  cup- 
former) were added, and used the extent of pro- 
tection against hypotonic hemolysis (13) as a crite- 
rion for the simultaneous binding of the two com- 
pounds (see Discussion). 
(b) The incubation of erythrocytes in unsupple- 
mented serum or  in buffered saline for  24  h  at 
37~  is known to markedly deplete the intracellu- 
lar ATP and to  crenate the  cells (16).  First we 
have provided additional evidence that the molec- 
ular mechanism of this crenation is different from 
that of drug-induced crenation, and then we have 
shown  that  the  crenated  cells  can  be  reversibly 
returned to  the  normal biconcave disk shape by 
the addition of the cup-former chlorpromazine. 
(c) Morphological evidence was sought to deter- 
mine whether mouse splenic lymphocytes undergo 
drug-induced shape changes comparable to those 
undergone by erythrocytes. 
(d)  Experiments were carried out on the "cap- 
ping" and endocytosis induced in mouse splenic B 
lymphocytes when these cells are treated with an- 
tibodies directed to their surface Ig receptor mole- 
cules (9,  18,  20).  The  rationale for our experi- 
ments was as follows. It is known (9, 18, 20) that 
2,4-dinitrophenol (DNP)  is  an  inhibitor of  the 
anti-Ig antibody-induced capping and endocytosis 
of these  lymphocytes. This inhibition has previ- 
ously been attributed to the fact that DNP is an 
uncoupler of mitochondrial oxidative phosphoryl- 
ation, and therefore to an energy requirement for 
the  processes of capping and endocytosis. How- 
ever, DNP is also an effective crenator of erythro- 
cytes. It therefore seemed possible that the effect 
of  DNP  in  inhibiting these  lymphocyte  surface 
phenomena was not due to its uncoupling activity, 
but rather to its direct effect on the lymphocyte 
plasma  membrane. The  geometry  of  the  shape 
change in endocytosis suggests,  according to the 
bilayer couple hypothesis, that the change involves 
an increase in the surface area of the  inner half 
relative to the outer half of the lymphocyte mem- 
brane. As a crenator, DNP might exert a compen- 
satory effect and increase the surface area of the 
outer half relative to the inner, and thus inhibit the 
endocytosis. One test of this proposal would be to 
compare 2,4,6-trinitrophenol (TNP) and DNP as 
inhibitors of these  lymphocyte surface  phenom- 
ena, since TNP is incapable of uncoupling oxida- 
tive phosphorylation in intact mitochondria (21, 
6) but, on the other hand, is as effective an eryth- 
rocyte crenator as DNP. We have  indeed found 
that TNP is at least as effective as DNP in inhibit- 
ing antibody-induced capping and endocytosis of 
lymphocytes.  All  of  these  experiments  have 
yielded results which are entirely consistent with 
the bilayer couple hypothesis, and therefore sug- 
gest its more general usefulness. 
MATERIALS  AND  METHODS 
Erythrocytes 
The collection of normal adult human erythrocytes, 
the procedure used in hemolysis  protection experiments, 
and  the  preparation  of  the  erythrocytes for  scanning 
electron microscopy in an ETEC Model R1 instrument 
were all performed as described previously (14). For the 
depletion experiments, washed erythrocytes at 50-70% 
hematocrit were incubated in isotonic buffered saline 
(146 mM NaCl, 20 mM Tris, pH 7.4, containing 100/zg/ 
ml each of penicillin and streptomycin) for 24 h at 37~ 
The viscosity of this suspension was followed in a low- 
shear Zimm-Crothers floating-bob viscometer (22), and 
was found to increase sharply upon depletion, as previ- 
ously reported (7). An aliquot of these cells was fixed for 
microscope examination by the addition of 1 vol of cells 
to l0 vol of 1% glutaraldehyde in 140 mM NaCI, 10 mM 
sodium phosphate,  pH  7.4.  Another aliquot was  re- 
moved, diluted to 3% hematocrit and treated with 300 
/xM chlorpromazine in the isotonic buffer for 10 min at 
37~  Part of this aliquot was fixed for microscopy; the 
rest  was  washed once  by  centrifugation in  drug-free 
buffer,  and  then  was fixed. To the  remainder of the 
depleted cells at 50-70% hematocrit was added enough 
dry adenosine to give a 5 mM solution and the mixture 
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suspension had returned nearly to normal, and a portion 
of these repleted cells was fixed and examined micro- 
scopically. 
Mouse Splenic Lymphocytes 
These cells were prepared from freshly killed  Swiss- 
Webster mice by standard procedures. For the experi- 
ments on the effects of drugs on lymphocyte morphol- 
ogy, the cells were suspended at a density of about 5 x 
107 per ml, in a buffer containing 146 mM NaCl and 20 
mM Tris, pH 7.4, and were then treated with 5 x  10  -5 
M chlorpormazine at room temperature. An aliquot of 
this suspension was removed after 10 min and fixed with 
a chlorpromazine-containing  glutaraldehyde solution (1) 
for examination in the scanning electron microscope. To 
the remaining unfixed suspension, 10 mM TNP in the 
isotonic NaCI-Tris  buffer was added, and, after 10 min, 
was fixed for electron microscopy. 
For  experiments  on  antibody-induced  lymphocyte 
capping and endocytosis, the following  procedure was 
used. First, rabbit antibodies directed to mouse Ig were 
bound to the lymphocyte surface at  0~  under which 
conditions no capping or endocytosis occurs. To 1 x  107 
cells in 1.0 ml of Hanks' balanced salt medium contain- 
ing 0.5% bovine serum albumin was added 0.1  ml (500 
~g) of the rabbit antibody at 0~  and the mixture was 
incubated at 0~  for 30 min. To one aliquot of cells was 
added, instead, an equivalent amount of normal rabbit 
T-globulin.  The cells were washed twice by centrifuga- 
tion  with  ice-cold medium  and  resuspended. Second, 
portions of the antibody-coated cells were subjected to 
one or  another treatment:  0.1-ml  aliquots of the  cell 
suspension were either (a) left at 0~  for another 20 min; 
(b) brought to 37~  for 20 min; (c) treated with 10 mM 
NaN3  (an  inhibitor  of capping  and  endocytosis) and 
brought to 37~  for 20 min; or (d) treated with a drug 
and  brought  to  37~  for  20  min.  Third,  fluorescein- 
labeled  goat  antibodies directed  to  rabbit  IgG  were 
added to these cells.  All samples described above were 
washed twice  by  centrifugation with  ice-cold  medium 
containing 10 mM NaNa, resuspended in 0.2 ml of that 
same medium, and mixed with 10 p.l of the fluorescent 
goat antibodies for 20 min at 0~  After two washes with 
the NaNa-containing  medium, the cells were fixed with 
2%  formaldehyde in 0.1  M  sodium phosphate buffer, 
pH 7.4. After another washing, the cells were examined 
by fluorescence microscopy. The fraction of fluorescent 
cells in the population was determined, and the fluores- 
cence was characterized as strong or weak, and as dif- 
fuse, patchy or capped. 
Experiments were also carded out to test the reversi- 
bility of the effects of drugs on the lymphocyte capping 
and endocytosis. Lymphocytes were first treated with a 
drug at a  particular concentration for 20  min at  37~ 
(pretreatment). The cells were then washed by centrifu- 
gation twice for various lengths of time in fresh medium 
at 0~  The cells were then subjected successively to the 
rabbit  anti-mouse Ig antibody treatment at  0~  to  a 
further incubation with or without the drug at 37~  and 
to the fluorescein-labeled goat anti-rabbit IgG antibod- 
ies; all as described above. 
Reagents 
DNP and TNP were recrystallized four times before 
use. Fluorescein isothiocyanate (10% on celite) was ob- 
tained from Calbiochem, La Jolla, Calif.  Oleate (99% 
pure) was purchased from Mallinckrodt Inc., St. Louis, 
Mo.  Chlorpromazine-HCl  was  the  generous  gift  of 
Smith,  Kline,  and  French  Laboratories,  Philadelphia, 
Pa. The preparation of the antibodies and the fluorescein 
isothiocyanate conjugation were carried out by standard 
procedures. Bovine serum albumin (Miles-Pentex Frac- 
tion  V,  Miles  Laboratories,  Inc.,  Elkhart,  Ind.)  was 
defatted by the method of Chen (2). 
RESULTS 
Combined Effects of Oleate and 
Chlorpromazine on Intact 
Erythrocytes 
Oleate is a well known crenator of erythrocytes 
and chlorpromazine a cup-former (3). In the same 
concentration  range  in  which  each  compound 
changes the cell shape, each affords the erythro- 
cyte protection against hypotonic hemolysis (Fig. 
1). Mixtures containing oleate at the constant con- 
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FIGURE  1  The protection against hypotonic hemolysis 
afforded human erythrocytes by the binding of different 
concentrations of oleate (O), chlorpromazine (D), and 
mixtures containing 2.5  x  10  -e M oleate and the indi- 
cated concentrations of chlorpromazine (A). The arrow 
indicates the  hemolysis protection afforded by  2.5  x 
10  -e M oleate itself. See text for further details. 
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trations of chlorpromazine were  tested  for  their 
effects  on  erythrocyte  shape  and  on  protection 
against hypotonic hemolysis. In such mixtures, the 
cells were crenated at chlorpromazine concentra- 
tions less than  1  x  10  -'~ M  and cupped at higher 
concentrations  (not  shown).  At  2.5  x  10  -6  M 
oleate and 1  x  10  -5 M chlorpromazine, the eryth- 
rocytes appeared to have their normal biconcave 
disk shape.  In mixtures containing 2.5  ￿  10  -6 M 
oleate and less than 2  x  10  -'~ M  chlorpromazine, 
the hemolysis protection was substantially greater 
than with either compound alone at its concentra- 
tion in the mixture (Fig.  1). 
Combined Effects of ATP Depletion and 
Chlorpromazine  on the Shape of 
Intact Erythrocytes 
The  well known crenation of erythrocytes that 
occurs from storage of human erythrocytes in un- 
supplemented serum or in buffered saline for 24 h 
at 37~  is shown in Fig. 2 b. If these cells are then 
treated with 5  mM adenosine at 37~  their nor- 
mal biconcave  disk  shape  is  restored  within 2  h 
(Fig. 2 c ). If the crenated ATP-depleted cells are 
treated  with  20 mg/ml of defatted  bovine serum 
albumin, there  is  no  change  in  cell  shape  (Fig. 
3 a,  b). It has been suggested (16) that the crena- 
tion that occurs upon ATP depletion is due to the 
formation of lysolecithin and its incorporation into 
the  membrane. Lysolecithin by itself is a  known 
erythrocyte crenator, as is shown in Fig. 3 c. (The 
cells here are so heavily crenated as to be nearly 
spherical in shape  [3].)  However,  as has already 
been  shown  (8),  iysolecithin-crenated  cells  are 
readily returned to normal shape (Fig. 3 d) by the 
same  bovine  serum  albumin  treatment  used 
above. The  inability of bovine serum albumin to 
affect the crenation of ATP-depleted cells there- 
fore  demonstrates  that  the  crenation  cannot  be 
FIGURE 2  Scanning electron  micrographs  of  normal 
human erythrocytes freshly  obtained from  serum and 
placed in the isotonic Tris-NaCl buffer, pH 7.4 (A); after 
24 h at 37~  in this buffer, leading to intraceUular ATP 
depletion (B); and 2 h after adding to the cells in B 5 mM 
adenosine (C). 
196  THE  JOURNAL OF  CELL BIOLOGY"  VOLUME 70,  1976 Ft6tJaE  3  Scanning electron micrographs of normal human erythrocytes in isotonic Tris-NaCl buffer: 
(A) after 24-h ATP-depletion; (B) cells in A treated with 20 mg/ml defatted bovine serum albumin for 10 
min at 4~  (C) fresh cells treated with 50/~g/ml lysolecithin for 1 min at 4~  and (D) cells in C treated 
with 20 mg/ml defatted bovine serum albumin for 10 min at 4~ 
attributed simply to the production of lysolecithin. 
Crenated  ATP-depleted  cells,  however,  are  re- 
stored to nearly normal shape by treatment with 3 
￿  10 -4 M  chlorpromazine (Fig. 4 b ); if these cells 
are  then  washed  in drug-free  isotonic buffer to 
remove the chlorpromazine, they return to their 
former crenated state (Fig. 4 c). 
TNP as an Erythrocyte Crenator 
At the  same concentration, TNP is somewhat 
more effective than DNP as a crenator of erythro- 
cytes (Fig. 5). That is, on the average the crena- 
tions are somewhat more numerous and of smaller 
radius in TNP- than in DNP-treated cells (14). 
The Effects of Drugs on Lymphocyte 
Morphology 
We sought to determine whether splenic lym- 
phocytes change shape in response to the addition 
of drugs  which  are  crenators or  cup-formers of 
erythrocytes. This was made difficult, however, by 
the  abundance of microvilli which  are  normally 
present in irregular array on lymphocyte surfaces 
(Fig.  6 a).  The ease with which these  microvilli 
are mechanically  sheared from the cell surface also 
complicates the problem. Given these difficulties, 
we were unable to determine whether any signifi- 
cant change in cell surface morphology was pro- 
duced by the addition of an erythrocyte crenator 
(e.g., 10 mM TNP). However, there was a signifi- 
cant  reduction  in  numbers of  microvilli and  a 
smoothing of the lymphocyte surface in 5  ￿  10 -5 
M  chlorpromazine,  the  erythrocyte  cup-former 
(Fig. 6 b). Furthermore, the addition of 10 mM 
TNP to  the  cells containing the  chlorpromazine 
resulted in the reappearance of numerous micro- 
villi (Fig. 6 c ). 
Antibody-Induced  Capping and 
Endocytosis of L ymphocytes 
By the technique described in the Methods sec- 
tion, the occurrence of antibody-induced endocy- 
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(A) after 24-h ATP-depletion; (B) cells in A  treated with 3  ￿  10  -4 M chlorpromazine for 1 rain at 4~  (C) 
cells in B  after a  100-fold dilution into buffer. 
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buffer after  treatment  for  1 min at 4"C  with: (A)  1 mM  2,4-dinitrophenol; and (B)  1 mM 2,4,6- 
trinitrophenol. 
tosis was scored in the following manner (9, 18). If 
the  rabbit antibodies to  mouse  Ig  had  induced 
extensive endocytosis in the second step, the rab- 
bit antibodies would then be  unavailable at  the 
surface of the B lymphocyte for labeling with the 
fluorescent-tagged goat  anti-rabbit IgG antibod- 
ies, and the population of cells would be largely 
unstained. If, however, extensive endocytosis had 
not occurred, the rabbit antibodies would be pres- 
ent  at  the  cell  surface,  and  the  B  lymphocytes 
(representing about 50% of the spleen cell popu- 
lation) would be strongly stained. 
The data collected in Table I  show that when 
lymphocytes were  incubated for  20  rain at  0~ 
with  rabbit anti-mouse Ig  antibody, 45-50%  of 
the cells were strongly fluorescent, with the fluo- 
rescence exhibiting a patchy distribution over the 
entire cell surface; if the incubation was done at 
37~  only 8-10%  of cells  were  weakly fluores- 
cent (corresponding to the fraction of cells in the 
population that  were found to  stain with  trypan 
blue); if  10  mM  NaNa  or  5-10  mM  DNP  was 
present during the  37~  incubation, the fluores- 
cence remained extensive, strong, and patchy. All 
of these results are as described before (9, 18, 20). 
The  new  findings are  that  5-10  mM TNP  also 
largely prevented capping and  endocytosis, and 
that even 1 mM TNP was significantly inhibitory. 
The results in Table II indicate that a prior treat- 
ment of lymphocytes with 10 mM DNP, followed 
by washing of the cells for only 10 min at 0~  had 
no effect on the subsequent antibody-induced  en- 
docytosis or its inhibition by a  second treatment 
with 10 mM DNP. The effects of pretreatment of 
the lymphocytes with 10 mM TNP could not be 
similarly reversed even by a longer washing proce- 
dure, but if 5 mM TNP was used in the pretreat- 
ment and washing was continued for 60  min at 
0~  significant but partial reversion was achieved. 
DISCUSSION 
The crux of this investigation  is the hypothesis (14, 
15) that because the two half-layers of biological 
membranes  are  different  in  their  composition, 
they may undergo different expansion or contrac- 
tion in response to  a  perturbation; if the  mem- 
brane  forms  a  closed  surface,  the  membrane 
would have to change its curvature. Perturbations 
which have similar effects on the ratios of outer 
and inner membrane surface areas should be syn- 
ergistic, whereas perturbations which have oppo- 
site effects should compensate one another. Sev- 
eral diverse experiments are  reported which ap- 
pear to bear out this suggestion. 
Normal  Drug-Erythrocyte  Interactions 
As an example of such a compensatory effect, 
when an erythrocyte crenator such as oleate and a 
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splenic  lymphocytes in  isotonic  Tris-NaCl  buffer:  (A) 
untreated; (B)  1 min after the addition to the cells in A 
of 5  x  10  -5  M  chlorpromazine  at  4~  and  (C)  1  min 
after  the  addition  to  the  cells  in  B  of  10  mM  2,4,6- 
trinitrophenol at 4~ 
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Effects of Drugs on Antibody-Induced Capping and 
Endocytosis of Lymphocytes 
Fluo- 
Concen-  rescent 
Drug  tration  cells*  Nature of fluorescence 
mM  % 
None  -  43~t  Strong, mostly patches 
10; 8  Weak, diffuse 
NaN3  10  34  Strong, patches 
DNP  10  50  Strong, patches 
5  33  Strong, patches 
TNP  10  54  Strong, patches 
5  37  Strong, mostly patches 
1  26  Strong, caps and patches 
* On the average, 10% of the cells stained with trypan 
blue; no correction was made for these dead cells. 
~t In this experiment, the cells were kept at 0~  for 20 
min in the second stage (Materials and Methods Sec- 
tion); all others were brought to 37  ~ for 20 min in the 
second stage. 
TABLE  II 
Reversibility of Drug Effects on Lymphocyte 
Endocytosis 
Second  Fluo- 
Pretreat-  Time of  treatment*  rescent 
Drug  ment* conch,  washing  conc.  cells 
None 
DNP 
TNP 
mM  mm  mM  % 
-  60  -  12 
10  10  10  49 
10  10  0  17 
10  10  10  54 
10  10  0  46 
10  60  0  46 
5  60  5  50 
5  60  0  28 
* For 20 min at 37"C. 
cup-former such as chlorpromazine are added to- 
gether  in  the  right  proportions,  the  erythrocyte 
recovers its normal biconcave disk shape (3). We 
have  shown  (Fig.  1)  that  such  mixtures confer 
upon erythrocytes greater protection against low 
ionic strength  hemolysis than  either  compound 
alone.  Hemolysis protection by  a  drug is  inter- 
preted to mean (13) that the drug causes an ex- 
pansion of the surface area of the membrane with- 
out a significant increase in cell volume, thus re- 
quiting a larger volume influx (and a longer time) 
to  burst  the  cell.  With  this  interpretation, the 
greater  hemolysis protection  obtained with  the 
mixture of 2.5  x  10 -6 M oleate and 1 x  10 -5 M 
chlorpromazine than  with  either  alone  strongly 
suggests that the  two compounds are  simultane- 
ously  bound when  the  erythrocyte  shape  is  re- 
stored to normal, and hence that the effects of the 
two compounds on shape cancel each other out. 
The Effects of ATP-Depletion on 
Erythrocyte Shape 
It  has  been  suggested  that  the  formation  of 
lysolecithin is  responsible  for  the  crenation  of 
erythrocytes upon ATP-depletion. By the results 
shown in Fig. 3, however, the crenation produced 
by ATP-depletion and by lysolecithin are readily 
distinguished upon treatment with bovine serum 
albumin. Also, ATP-depleted crenated cells  are 
known to be much more rigid than drug-crenated 
cells  (7), again suggesting that although the cells 
appear  similar,  a  different  mechanism  for  the 
crenation is involved in the two cases. 
In a separate study (Sheetz and Singer, manu- 
script in preparation) we have obtained evidence 
that ATP-depletion produces a  disaggregation of 
the spectrin complex (10) which is attached to the 
inner surface of the erythrocyte membrane (11). 
We  propose  that  this  disaggregation  somehow 
causes an increase in the ratio of the surface areas 
of the outer vs. inner half-layers of the erythrocyte 
membrane, leading to the crenation. For our pres- 
ent purposes, the precise details of this mechanism 
are not important, so long as it is accepted that the 
crenation occurring upon ATP-depletion is differ- 
ent in mechanism from  drug-induced crenation. 
Under these circumstances, the fact that the cup- 
forming drug  chlorpromazine can  restore  ATP- 
depleted  crenated  cells  to  nearly normal shape 
(Fig. 4 b ) is therefore a new kind of compensatory 
shape  change,  different  from  that  considered 
above  when  two  shape-compensating drugs  are 
used.  Here  we  suggest  that  the  intercalation of 
chlorpromazine perferentially into the lipid in the 
inner half-layer of the bilayer compensates for the 
opposite  area  changes  that  are  induced by  the 
ATP-depletion. Further indication of the compen- 
satory nature of the shape change is the fact that 
washing out the  chlorpromazine from the  mem- 
brane restores  the  cell  to  its ATP-depleted cre- 
hated state (Fig. 4 c). 
The Effects of Drugs on 
Lymphocyte Morphology 
The discussion to this point has been confined to 
adult human erythrocytes and the shape changes 
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the erythrocyte membrane  than  any other at the 
present time, and the  asymmetrical distributions 
of its proteins and phospholipids in the two halves 
of the membrane are well documented (17). How 
general  are  such  asymmetrical  distributions  for 
membranes  other  than  erythrocyte membranes? 
That the proteins of many membranes are asym- 
metrically oriented and distributed is reasonably 
well established (17), and, in some cases, sugges- 
tive evidence has been obtained that the distribu- 
tion of their phospholipids is also asymmetric (19). 
As an indirect approach to the latter problem, we 
may  ask  whether  lymphocytes,  for  example, 
change shape in an analogous fashion to erythro- 
cytes  upon  treatment  with  specific  amphipathic 
drugs. If so, and if our explanation of these drug- 
induced  erythrocyte  shape  changes  is  accepted, 
such  results  would  suggest  that  the  zwitterionic 
and  anionic  phospholipids  in  the  lymphocyte 
plasma membrane are organized as they are in the 
erythrocyte membrane. Because lymphocytes are 
normally covered with irregular masses of numer- 
ous microvilli, it was difficult to tell whether eryth- 
rocyte crenators induced any further crenation of 
these cells. However, the erythrocyte cup-former 
chlorpromazine at 5  ￿  10 -'~ M produced lympho- 
cytes with a much smoother surface than normal, 
with many  fewer microvilli (Fig. 6 a  and b ); the 
addition of 10 mM TNP to the cells in chlorpro- 
mazine induced the reformation of numerous mi- 
crovilli (Fig. 6 c ). These changes are analogous to 
those  produced  with  erythrocytes when  treated 
successively with a  cup-former and a  crenator as 
discussed above. These results are therefore con- 
sistent with, but do not prove, the proposal that 
the plasma membrane of the lymphocyte is molec- 
ularly asymmetric much like the erythrocyte mem- 
brane,  and responds to drugs by similar mecha- 
nisms (14). 
In these lymphocyte experiments, and in others 
discussed below, TNP  is used as an analogue of 
DNP.  The experiments shown in Fig. 5 establish 
that TN.P is indeed an effective crenator of intact 
erythrocytes in the concentration range of about 
1-10  mM,  and,  if anything,  is  somewhat  more 
effective than DNP at the same concentration. 
The Effects of DNP and TNP on 
Lymphocyte Surface  Phenomena 
Our results on the effects of erythrocyte crena- 
tors on antibody-induced capping and endocytosis 
of mouse splenic lymphocytes show that TNP is at 
least as effective as DNP  in  inhibiting both  the 
capping and endocytosis (Table I). This inhibition 
is more difficult to reverse than with DNP added 
at the same concentration (Table II), but this may 
be due to TNP binding more strongly to the mem- 
brane, or to its slower flip-rate in the membrane 
(15). These results vitiate the conclusion that the 
inhibitory effect  of DNP  is  connected  with  the 
uncoupling  of mitochondrial oxidative phospho- 
rylation, since TNP is not an uncoupler with intact 
cells and mitochondria (6, 21). This is not to say 
that the lymphocyte capping and endocytosis do 
not require energy; in fact the inhibition of these 
processes  by  NaN3  suggests  that  they  do.  The 
inhibitory effect of DNP, however, can no longer 
be taken as evidence for such an energy require- 
ment. 
One  possible explanation for the inhibition by 
DNP  and TNP is that suggested in the introduc- 
tory  paragraph:  namely  that  the  lymphocyte 
plasma  membrane,  like  the  erythrocyte  mem- 
brane,  behaves like a  bilayer couple, that  those 
compounds that crenate the erythrocyte act by a 
similar intercalation mechanism  on  the  lympho- 
cyte membrane, and that, in doing so, they induce 
surface area and shape changes that are opposite 
to those presumed to be involved in capping and 
endocytosis; i.e. that the inhibition is due to com- 
pensatory shape changes. While this explanation is 
consistent with the results obtained, it is not estab- 
lished by them, and certain features of the expla- 
nation clearly require more direct substantiation. 
For example, while the geometry of the endocy- 
totic events suggests that an increase in the ratio of 
inner  to  outer  surface  areas  of the  lymphocyte 
membrane  is  involved,  there  is no  independent 
evidence that such an area change is also involved 
in capping. The  clustering of Ig receptors into a 
cap by anti-Ig antibodies might in principle lead to 
such  area  changes,  and  to  corresponding  shape 
changes, but the lymphocyte plasma membrane is 
so convoluted in appearance in thin sections exam- 
ined by transmission electron microscopy that one 
cannot determine whether capped regions of the 
membrane are altered in shape. More studies are 
required  to  demonstrate  how  these  lymphocyte 
surface  phenomena  are  affected  by  a  range  of 
compounds that in the appropriate concentration 
range are erythrocyte crenators and cup-formers. 
Our results show that, whatever the mechanism 
by  which  they  operate,  DNP  and  TNP  have  a 
direct  effect  on  the  lymphocyte  plasma  mem- 
brane. The mechanisms whereby other drugs (12) 
affect lymphocyte surface phenomena may also be 
direct effects on  the  plasma  membrane.  Colchi- 
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bules in these phenomena, but, at concentrations 
of 0.1  mM,  colchicine is an effective erythrocyte 
cup-former  (3),  indicating that it can interact di- 
rectly with the membrane. 
Finally, the usefulness of the bilayer couple hy- 
pothesis,  in  explaining and predicting the results 
discussed in this paper, suggests that the hypothe- 
sis may be relevant for a  variety of cellular phe- 
nomena in which membrane shape changes occur. 
Such shape changes may involve, at least locally, a 
change in the relative areas of the inner and outer 
half-layers of the particular bilayer membrane, 
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